SLC25A5 Antibody
-
中文名称:SLC25A5兔多克隆抗体
-
货号:CSB-PA021518LA01HU
-
规格:¥440
-
图片:
-
其他:
产品详情
-
产品名称:Rabbit anti-Homo sapiens (Human) SLC25A5 Polyclonal antibody
-
Uniprot No.:
-
基因名:
-
别名:SLC25A5; AAC2; ANT2; ADP/ATP translocase 2; ADP,ATP carrier protein 2; ADP,ATP carrier protein, fibroblast isoform; Adenine nucleotide translocator 2; ANT 2; Solute carrier family 25 member 5
-
宿主:Rabbit
-
反应种属:Human
-
免疫原:Recombinant Human ADP/ATP translocase 2 protein (144-175AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
本页面中的产品,SLC25A5 Antibody (CSB-PA021518LA01HU),的标记方式是Non-conjugated。对于SLC25A5 Antibody,我们还提供其他标记。见下表:
-
克隆类型:Polyclonal
-
抗体亚型:IgG
-
纯化方式:>95%, Protein G purified
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA, WB, IHC
-
推荐稀释比:
Application Recommended Dilution WB 1:500-1:5000 IHC 1:500-1:1000 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相关产品
靶点详情
-
功能:ADP:ATP antiporter that mediates import of ADP into the mitochondrial matrix for ATP synthesis, and export of ATP out to fuel the cell. Cycles between the cytoplasmic-open state (c-state) and the matrix-open state (m-state): operates by the alternating access mechanism with a single substrate-binding site intermittently exposed to either the cytosolic (c-state) or matrix (m-state) side of the inner mitochondrial membrane. In addition to its ADP:ATP antiporter activity, also involved in mitochondrial uncoupling and mitochondrial permeability transition pore (mPTP) activity. Plays a...显示更多
-
基因功能参考文献:
- Findings suggest that ANT2 overexpression contributes to EGFR-TKI resistance in non-small cell lung cancer. PMID: 26883272
- Study found that ANT2 was upregulated in sorafenibresistant hepatocellular carcinoma Huh7 cell line and its overexpression promoted sorafenib resistance. PMID: 28350139
- cancer cells require both hANT2 and hANT3, depending on their proliferation status: hANT2 when proliferation rates are high, and hANT3 when proliferation slows. PMID: 26842067
- ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells. PMID: 27012708
- IFNgamma induces oxidative stress, DNA damage and tumor cell senescence via TGFbeta/SMAD signaling-dependent induction of Nox4 and suppression of ANT2 PMID: 25982278
- TGF-beta-mediated suppression of ANT2 through NF1/Smad4 complexes contributes to oxidative stress and DNA damage during induction of cellular senescence. PMID: 25220407
- Sirt4 regulates ATP levels via ANT2 and a feedback loop involving AMPK. PMID: 24296486
- ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression PMID: 23242177
- SLC25A5 is involved in memory formation or establishment, which could add mitochondrial processes to the wide array of pathways that regulate normal cognitive functions. PMID: 23783460
- miR-636 might function as a tumor suppressor miRNA affecting hepatocellular carcinoma (HCC) tumorigenesis via downregulation of Ras, and that ANT2 suppression by shRNA could exert an anticancer effect by restoring miR-636 expression in HCC. PMID: 23306701
- Apigenin upregulates DR5 and enhances TRAIL induced apoptosis by binding and inhibiting ANT2. PMID: 23431365
- The mammalian proteins MMS19, MIP18, and ANT2 are involved in cytoplasmic iron-sulfur cluster protein assembly. PMID: 23150669
- In the context of ovarian cancer, the interaction between CKIepsilon and ANT2 mediates pathogenic signalling that is distinct from the canonical Wnt/beta-catenin pathway and is essential for cell proliferation and is clinically associated with poor survival. PMID: 22707389
- ANT2 is not pro-apoptotic and may therefore contribute to carcinogenesis. PMID: 20950584
- ANT2 shRNA treatment sensitized MCF7, T47 D, and BT474 cells to TRAIL-induced apoptosis by up-regulating the expression of TRAIL death receptors 4 and 5 (DR4 and DR5) and down-regulating the TRAIL decoy receptor 2 (DcR2). PMID: 20875141
- ANT2 is able to restore growth on a nonfermentable carbon source of a yeast mutant strain lacking its three endogenous ANC. PMID: 12450408
- enhanced binding of NF1 is a key step in the growth arrest repression of ANT2 transcription. PMID: 12777383
- expression under hypoxic conditions alters cell cycle in cancer cells PMID: 15486956
- Growth-dependent repression of human adenine nucleotide translocator-2 (ANT2) transcription. PMID: 18215124
- ANT2-specific RNA interference approach to inhibit ANT2 expression resulted in breast cancer cell growth arrest PMID: 18267033
收起更多
-
亚细胞定位:Mitochondrion inner membrane; Multi-pass membrane protein. Membrane; Multi-pass membrane protein.
-
蛋白家族:Mitochondrial carrier (TC 2.A.29) family
-
组织特异性:Expressed in erythrocytes (at protein level).
-
数据库链接: